Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Interest & Investment Income (2016)

Lixte Biotechnology Holdings' Interest & Investment Income history spans 7 years, with the latest figure at $11.0 for Q4 2016.

  • For Q4 2016, Interest & Investment Income changed N/A year-over-year to $11.0; the TTM value through Dec 2016 reached $184.0, changed N/A, while the annual FY2025 figure was $7388.0, 4.82% up from the prior year.
  • Interest & Investment Income reached $11.0 in Q4 2016 per LIXT's latest filing, down from $141.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $27437.0 in Q4 2013 to a low of $1.0 in Q2 2012.
  • Average Interest & Investment Income over 5 years is $3066.2, with a median of $11.0 recorded in 2015.
  • Peak YoY movement for Interest & Investment Income: crashed 97.3% in 2012, then skyrocketed 2700.0% in 2014.
  • A 5-year view of Interest & Investment Income shows it stood at $27434.0 in 2012, then rose by 0.01% to $27437.0 in 2013, then plummeted by 99.9% to $27.0 in 2014, then dropped by 7.41% to $25.0 in 2015, then crashed by 56.0% to $11.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Interest & Investment Income are $11.0 (Q4 2016), $141.0 (Q3 2016), and $21.0 (Q2 2016).